About This Video
Award-winning device designed for patient ease of use, reliability and convenience EMD Serono, Inc. announced today the availability of easypod, the first of its kind automated device in the growth hormone therapeutic area. easypod was developed for the administration of Saizen [somatropin (rDNA origin) for injection], the company's treatment for growth hormone deficiency. A 2007 Gold Medal recipient of the Medical Design Excellence Awards, easypod was designed in conjunction with patients, caregivers and healthcare professionals to answer the need for a device that provided simple everyday use while monitoring patient adherence. On October 31, 2007, easypod received approval from the US Food and Drug Administration (FDA) and is now available to patients through their healthcare providers.
Recommended Videos
This website uses Adobe® Flash™ Player 9
Download Flash Now
If you are using Internet Explorer, you will need to restart your browser
after installing Flash.
Adobe and Flash are registered trademarks of Adobe Systems incorporated.
All rights reserved.